New Aspects in the Diagnosis and Treatment of Hodgkin¿s Disease
77,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 1-2 Wochen
payback
39 °P sammeln
  • Broschiertes Buch

In the field of Hodgkin's lymphoma, many new data have been collected during the last decade both on the cell of origin of this disease and on more effective therapies to cure the majority of pa tients even in the advanced stages. Therefore, it seems to be justi fied to compile these new data in a special volume of Recent Re sults in Cancer Research. This volume summarizes the contribu tions presented at the First International Symposium on Hodgkin's Disease that took place in Cologne (FRG) on October 2-3, 1988. There is little doubt that the Hodgkin and Reed-Sternberg (H and RS) cells and…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
In the field of Hodgkin's lymphoma, many new data have been collected during the last decade both on the cell of origin of this disease and on more effective therapies to cure the majority of pa tients even in the advanced stages. Therefore, it seems to be justi fied to compile these new data in a special volume of Recent Re sults in Cancer Research. This volume summarizes the contribu tions presented at the First International Symposium on Hodgkin's Disease that took place in Cologne (FRG) on October 2-3, 1988. There is little doubt that the Hodgkin and Reed-Sternberg (H and RS) cells and their variants represent the malignant population in Hodgkin's lymphoma; however, there is still a fierce debate as to the possible cell of origin of Hand RS cells. Many of the problems confounding earlier research into this question were related to the difficulty or virtual impossibility, of obtaining purified populations of Hand RS cells. Most of the recent progress stems from the establishment of permanent cell lines of Hand RS cells in culture.
Autorenporträt
Prof. Dr. med. Volker Diehl, absolvierte eine Ausbildung in Innerer Medizin, klinischer Virologie und Hämato-Onkologie am Children's Hospital in Philadelphia, am Karolinska Institut in Stockholm und an der Med. Hochschule Hannover. Bis 1983 arbeitet er am Aufbau der Arbeitsgruppe für internistische Onkologie an der Med. Hochschule Hannover, seit 1983 ist er Ordinarius für Innere Medizin in Köln. Seine Arbeits- und Forschungsschwerpunkte sind: Innere Medizin, Hämatologie, Onkologie, Infektionskrankheiten und Immunologie. Seit 1994 ist er Mitglied im Editorial Board des NEW ENGLAND JOURNAL OF MEDICINE, 1995- 2001 war er Vorsitzender der Deutschen Gesellschaft für Hämatologie und Onkologie (DGHO),1999 war er Vorsitzender der Deutschen Gesellschaft für Innere Medizin (DGIM).